Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients with COVID‐19: A rapid systematic review and meta‐analysis

An association among the use of angiotensin converting enzyme (ACE) inhibitors and angiotensin‐receptor blockers (ARBs) with the clinical outcomes of coronavirus disease 2019 (COVID‐19) is unclear. PubMed, EMBASE, MedRxiv, and BioRxiv were searched for relevant studies that assessed the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiao, Long, Chuyan, Xiong, Qinmei, Chen, Chen, Ma, Jianyong, Su, Yuhao, Hong, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436520/
https://www.ncbi.nlm.nih.gov/pubmed/32757246
http://dx.doi.org/10.1002/clc.23421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436520/
https://www.ncbi.nlm.nih.gov/pubmed/32757246
http://dx.doi.org/10.1002/clc.23421

Ejemplares similares